The composition of the essential oil of Thymus pulegioides and its antifungal activity on Candida, Aspergillus and dermatophyte fungal strains were studied. Essential oil from the aerial parts of the plant was obtained by hydrodistillation and analysed by GC and GC-MS. The oil showed high contents of carvacrol and thymol. The MIC and minimal lethal concentration were used to evaluate the antifungal activity against Candida (seven clinical isolates and four ATCC type strains), Aspergillus [five clinical isolates, and two Colecció n Españ ola de Cultivos Tipo (CECT) and two ATCC type strains] and five clinical dermatophyte strains. Antifungal activity was evaluated for the essential oil and for its main components. To clarify its mechanism of action on yeasts and filamentous fungi, flow-cytometric studies of cytoplasmic membrane integrity were performed, and the effect on the amount of ergosterol was investigated. Results showed that T. pulegioides essential oil exhibited a significant activity against clinically relevant fungi, mainly due to lesion formation in the cytoplasmic membrane and a considerable reduction of the ergosterol content. The present study indicates that T. pulegioides essential oil has considerable antifungal activity, deserving further investigation for clinical applications.
INTRODUCTION
Fungal infections have been increasing in recent years due to a growing number of high-risk patients, particularly immunocompromised hosts. Candida is the third-or fourth-most-common isolate in nosocomial bloodstream infections in the USA. In addition, candidosis is the most common invasive fungal infection in critically ill nonneutropenic patients (Eggimann et al., 2003) . The mortality rate due to invasive aspergillosis increased by 357 % between 1980 and 1997 in the USA (McNeil et al., 2001) . Dermatomycoses are common infections caused by members of the genus Candida and by filamentous fungi, particularly the dermatophytes. Superficial candidosis and dermatophytosis can be severe in immunocompromised patients.
In spite of the introduction of new antifungal drugs, they are limited in number. The increase of fungal resistance to classical drugs, the treatment costs, and the fact that most available antifungal drugs have only fungistatic activity, justify the search for new strategies (Rapp, 2004) .
Aromatic plants have been widely used in folk medicine. It is known that most of their properties are due to their volatile oils. Essential oils from many plants are known to possess antifungal activity (Kalemba & Kunicka, 2003) , but only limited information exists about activity toward human fungal pathogens. They have been empirically used as antimicrobial agents, but the mechanisms of action are still unknown.
important antifungal activity against yeasts, dermatophyte fungi and Aspergillus strains, which could predict therapeutic benefits, mainly for diseases with mucosal, cutaneous and respiratory tract involvement.
Several studies have shown that thyme oils, particularly those of Thymus vulgaris and Thymus zygis (Bruneton, 1999; Pina-Vaz et al., 2004; Stahl-Biskup & Sáez, 2002) , possess antimicrobial activity, those of the phenol type being the most active. The limited occurrence of these phenols in nature is one of the reasons why Thymus oils containing thymol and carvacrol have been of great interest for some time.
Thymus pulegioides is widely distributed on the European continent south of the Mediterranean isles. In Portugal, it grows in the northeast, and it is locally used as an antiseptic. Previous results have demonstrated that this species is polymorphic (Salgueiro, 1994; Stahl-Biskup & Sáez, 2002) , and that the thymol/carvacrol chemotype is one of the most abundant in Portugal.
The objective of our present research was to evaluate the antifungal activity and investigate the mechanism of action of this specific chemotype and of its main components.
METHODS
Fungal organisms. The antifungal activity of the essential oil and its main components was evaluated against Candida, Aspergillus and dermatophyte strains: seven clinical Candida strains, two of Candida albicans (M1, H37), one of Candida krusei (H9), one of Candida tropicalis (H18), one of Candida guillermondii (Mat23) and two of Candida glabrata (H16, H30) isolated from recurrent cases of vulvovaginal candidosis, and four ATCC type strains (C. albicans ATCC 10231, C. tropicalis ATCC 13803, Candida parapsilosis ATCC 90018 and C. krusei ATCC 6258); five Aspergillus clinical strains, one of Aspergillus niger (F01), three of Aspergillus fumigatus (F05, F07 and F17) and one of Aspergillus flavus (F44) isolated from bronchial secretions, as well as two ATCC type strains (A. niger ATCC 16404 and A. fumigatus ATCC 46645) and two CECT type strains (A. niger CECT 2574 and A. fumigatus CECT 2071); and five dermatophyte clinical strains (Microsporum canis FF1, Microsporum gypseum FF3, Trichophyton rubrum FF5, Trichophyton mentagrophytes FF7 and Epidermophyton floccosum FF9) isolated from nails and skin.
C. parapsilosis ATCC 90018 and C. krusei ATCC 6258 were used as controls. The fungal isolates were identified by standard microbiology methods and stored in Sabouraud dextrose broth with glycerol at 270 uC.
Plant material and chemicals. Aerial parts of the plants were collected at the flowering stage from Moimenta, Trás-os-Montes (north of Portugal). A voucher specimen was deposited at the Herbarium of the Instituto Botânico of the University of Coimbra (COI).
Thymol (99?5 %) was purchased from DBH, and carvacrol, c-terpinene and p-cymene (all 99?5 %) from Fluka.
Essential oil analysis. Essential oil was isolated by water distillation for 3 h from air-dried material, using a Clevenger-type apparatus, according to the procedure described in the European Pharmacopoeia (Council of Europe, 1997 The identity of the components was ascertained based on their retention indices, calculated by linear interpolation relative to retention times of a series of n-alkanes, and their mass spectra, which were compared with those from our own library and literature data (Adams, 1995; Joulain & Konig, 1998) . Relative amounts of individual components were calculated based on GC peak areas without FID response factor correction.
Antifungal activity. MICs, determined by the macrodilution broth method, and minimal lethal concentrations (MLCs) were performed according to reference documents M27-A and M38-A (National Committee for Clinical Laboratory Standards, 1997 Standards, , 2002 for yeasts and filamentous fungi, respectively. Serial twofold dilutions in DMSO, ranging from 0?02 to 20 ml ml 21 , were tested for essential oil and its main components (thymol, carvacrol, p-cymene and c-terpinene). In addition, the reference antifungal compounds, fluconazole (Pfizer) for yeasts and dermatophytes, or amphotericin B (Sigma) for Aspergillus, were used as standard antifungal drugs. Twofold serial dilutions ranging from 0?25 to 128 mg ml 21 for fluconazole and 0?016 to 16 mg ml 21 for amphotericin B were used.
Quality control determinations of the MICs of fluconazole and amphotericin B were performed by testing C. parapsilosis ATCC 90018 and C. krusei ATCC 6258. The results obtained were within the recommended limits.
These experiments performed in duplicate were repeated independently three times and yielded essentially the same results. A range of values is presented where different results were obtained. Two growth controls, RPMI medium and RPMI with 2?0 % (v/v) DMSO, were included for each strain.
Mechanism of activity
Lesion of cytoplasmic membrane. Flow cytometry analysis using propidium iodide (PI; Sigma) was performed. PI is a fluorescent probe used to study the effect of drugs on membranes. It only penetrates cells with severe membrane lesions, showing increased red fluorescence (Pina-Vaz et al., 2001) . Cells (10 6 ml 21 ) were incubated with serial concentrations of the oil and its main components (0?32-1?25 ml ml
21
) for 1 h (Candida) or 7 h (Aspergillus), and then stained with 1 mg PI ml 21 for 30 min. Cells were also incubated with the same compounds, at MLC values, for 5, 10, 15 and 30 min at 30 uC for C. albicans, representing yeasts, and 3, 5, 7 and 16 h for A. fumigatus and A. niger, representing moulds. Scattergram analysis was performed to evaluate morphological changes (size and complexity). The percentage of stained cells at FL3 (620 nm, red), representing dead cells with severe lesions of the membrane, was quantified.
Study of ergosterol amount. For determination of the amount of ergosterol, the strains were incubated in RPMI medium (Sigma) supplemented with 2 % glucose (Difco) for 48 h at 35 uC (yeasts), 3 days at 25 uC (Aspergillus) or 5 days at 25 uC (dermatophytes), while shaking. A quantification of ergosterol amount was performed after incubation with and without the essential oil, its main components, or fluconazole as control, at both MIC and subinhibitory concentrations. Ergosterol was isolated from fungal cells by saponification, and the non-saponifiable lipids were extracted with heptane. Ergosterol was identified by its spectrophotometric absorbance profile (230-300 nm) (Arthington-Skaggs et al., 1999).
RESULTS AND DISCUSSION
The oil was obtained from air-dried plant material in a yield of 1?8 % (v/w). The qualitative and quantitative composition of the oil analysed is shown in Table 1 . Fifty-seven components representing 98?5 % of the volatile oil were identified. The oil was characterized by high amounts of thymol (26?0 %), and of carvacrol (21?0 %) and its biogenetic precursors, c-terpinene (8?8 %) and p-cymene (7?8 %) (thymol/carvacrol chemotype).
Evaluation of MIC and MLC showed that the oil was active against all the tested strains (Table 2) . T. pulegioides essential oil exhibited significant antifungal activity. MIC values DRI SPB-1 signifies GC-retention indices relative to C 9 -C 23 n-alkanes on the SPB-1 column. dRI SW 10 signifies GC-retention indices relative to C 9 -C 23 n-alkanes on the Supelco Supelcowax-10 column. *MIC and MLC were determined by a macrodilution method and expressed in ml ml 21 (v/v).
DMIC and MLC were determined by a macrodilution method and expressed in mg ml 21 (w/v).
ranged from 0?16 to 0?32 ml ml 21 against dermatophyte and Aspergillus strains. Candida showed the highest MIC values, ranging from 0?32 to 0?64 ml ml 21 . For Candida and most dermatophyte strains, MIC and MLC values were similar, ranging from 0?16 to 0?64 ml ml 21 (Table 2 ). It is difficult to attribute the activity of a complex mixture to particular constituents. Nevertheless, it is reasonable to speculate that the activity of this oil can be related to the presence of carvacrol and thymol. These compounds were found to be the most active constituents (Table 2) of T. pulegioides oil, with MIC values ranging from 0?04 to 0?32 ml ml 21 and 0?08 to 0?32 ml ml
21
, respectively. The importance of the phenolic hydroxyl groups for the antimicrobial activity of the monoterpenoids has previously been reported (Adam et al., 1998; Aligiannis et al., 2001; Dorman & Deans, 2000; Nostro et al., 2004; Sivropoulou et al., 1996) . Other species of the genus Thymus, such us T. zygis and T. vulgaris, with high amounts of phenols, also show a broad spectrum of activity against a variety of pathogenic yeasts and filamentous fungi, including fungi with decreased susceptibility to fluconazole (Dorman & Deans, 2000; Nguefack et al., 2004; Pina-Vaz et al., 2004) . Nevertheless, carvacrol proved to be more active against dermatophyte strains, in a similar manner to the essential oil. MIC and MLC values were very similar and the fungistatic and fungicidal properties of the oil were suspected to be associated with high carvacrol and thymol content.
Flow cytometry was used to evaluate the effect of the essential oil on the integrity of fungal cells, using PI as fluorescent marker. The results showed that the oil acts by primary lesion of the membrane. The effect on Candida was fungicidal, with severe lesion of the membrane, as PI could penetrate most of the yeast cells (more than 95 %) after 5 min at the MLC value (0?64 ml ml
). This effect was dose dependent, so that there were >95 % PI-positive cells at a sub-MLC concentration (0?32 ml ml
). Substantial morphological changes were observed on a scattergram of C. albicans cells after 1 h incubation at MLC values (Fig. 1) . Previous work carried out with essential oils has revealed anti-Candida activity (Pina-Vaz et al., 2004; Salgueiro et al., 2003 Salgueiro et al., , 2004 . Incubating Aspergillus with essential oil of T. pulegioides, PI began to stain the cells after 7 h incubation. At MLC values,~40 % of A. fumigatus cells and~20 % of A. niger cells were stained, the effect being dose dependent (Fig. 2) . Thymol and carvacrol gave identical cytometric results to T. pulegioides essential oil against Candida and Aspergillus. To understand the mechanism of action on moulds, Aspergillus species were studied as typical. Aspergillus begins its germination at~7 h incubation, so it is understandable that it was only after this period that the essential oil was effective and PI could enter the cells. This effect is superior to the effect of most antifungals, as most of them are fungistatic.
Ergosterol is the major sterol component of the yeast cell membrane, and is responsible for maintaining cell function and integrity (Rodriguez et al., 1985) . The primary mechanism of action by which azole antifungal drugs inhibit yeast cell growth is disruption of normal sterol biosynthetic pathways, leading to a reduction in ergosterol biosynthesis (Kelly et al., 1995) . After incubation of C. albicans ATCC 10231 at MIC (0?64 ml ml
) and subinhibitory (0?32 ml ml 21 ) concentrations of essential oil, a reduction of 80-100 % of ergosterol content was observed. A similar effect was obtained with fluconazole at 1 mg ml 21 . For T. rubrum, a subinhibitory essential oil concentration (0?08 ml ml 21 ) reduced ergosterol content by around 70 %. The essential oil of T. pulegioides therefore induces considerable impairment of the biosynthesis of ergosterol by C. albicans and T. rubrum.
The large spectrum of activity of this essential oil acting on Candida, Aspergillus and dermatophytes agrees with the mechanism of action proposed: cytoplasmic membrane lesion.
In conclusion, the findings of the present study indicate that T. pulegioides essential oil has potential as a topical antifungal agent against fungi that are pathogenic to humans. This essential oil is a broad-spectrum agent that inhibites not only dermatophytes, Aspergillus and Candida species (such as C. albicans, C. tropicalis, C. parapsilosis, C. guilliermondii), but also fluconazole-resistant C. albicans isolates, and C. krusei and C. glabrata, which are intrinsically resistant to fluconazole or whose resistance is easily inducible.
Given the results described above, particularly the possible mechanisms of action, which might induce side-effects in humans, these antifungals require further investigation.
The results presented should stimulate studies on toxicity, improved formulations and the determination of optimal concentrations for clinical applications, as well as comparative studies alongside currently used drugs of the therapeutic efficacy of essential oils to control mucocutaneous infections.
